NCT03989856

Brief Summary

In women undergoing laparoscopic ovarian cystectomy which is less harmfull on the ovarian reserve (electrocoagulation or suturing).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 15, 2019

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 15, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 18, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 20, 2019

Completed
Last Updated

June 18, 2019

Status Verified

June 1, 2019

Enrollment Period

6 months

First QC Date

June 15, 2019

Last Update Submit

June 17, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Ovarian reserve

    By measuring Anti-mullerian hormone

    3 months

Study Arms (2)

Suturing group

EXPERIMENTAL

The sutures will be performed with intracorporeal knots using 2-0 polyglican absorbable sutures (Vicryl; Ethicon Inc., New Jersey, USA). Suture is performed using needle holders for the closure of ovarian parenchyma and controlling bleeding. Bleeding from ovarian hilus will only resolve by suturing. The running suture starting from central area, around the ovarian hilus to peripheral tissue, will be performed with intraovarian knots to re-approximate the edges to achieve satisfying hemostasis. Knots will not be detectable on the ovarian surface for prevention of adhesion. Mean time for hemostasis of ovary was recorded in a form. The cyst wall will be removed from the abdomen by means of an endobag. All resected cyst walls will be sent to the pathology laboratory, to confirm the histopathology of endometriosis.

Device: 2-0 polyglican absorbable sutures

Bipolar group

ACTIVE COMPARATOR

In bipolar coagulation group, after stripping the ovarian cyst wall, bipolar coagulation technique will be used to control significant bleeding (40 W current; Richard Wolf, Germany). In laparoscopic suturing group, no bipolar coagulation will be performed during or after stripping the ovarian cyst wall.

Device: Diathermy

Interventions

The sutures will be performed with intracorporeal knots using 2-0 polyglican absorbable sutures (Vicryl; Ethicon Inc., New Jersey, USA). Suture is performed using needle holders for the closure of ovarian parenchyma and controlling bleeding. Bleeding from ovarian hilus will only resolve by suturing.

Suturing group
DiathermyDEVICE

bipolar coagulation technique will be used to control significant bleeding (40 W current; Richard Wolf, Germany). I

Bipolar group

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18- 45.
  • Regular menstrual cycle.
  • Unilateral ovarian cyst clinical \& us finding as endometriotic cyst.
  • C/O of pelvic pain.
  • No medications (oral pills \& hormonal drugs) in the past 3 monthes before enrollement.
  • No evidence of endocrine disorders (DM, Thyroid dysfunction,hyper prolactenemia, congenital adrenal hyperplesia, cushing's syndrome or adrenal insufficiency)
  • No previous adnexial surgery.
  • Pathology diagnosis of excised ovarian tissue (endometriotic cyst)
  • Appropriate medical condition for laparoscopic surgery.
  • Completely understand the process of the study with written consent.

You may not qualify if:

  • PCO according to Rotterdam criteria.
  • Pathological diagnosis of excised ovarian tissue as non endometriotic cyst.
  • Previous ovarian surgery.
  • Suspected ovarian malignancy.
  • Patient whose histopathology showed benign cyst apart from endometrioma.
  • Irregular menstrual cycles.
  • Post menopausal status.
  • Bilateral ovarian cyst.
  • AMH \< 0.5 ng/ml.
  • Premature ovarian failure in family.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain shams maternity teaching hospital

Cairo, Abbasia, 11591, Egypt

RECRUITING

MeSH Terms

Interventions

Diathermy

Intervention Hierarchy (Ancestors)

Hyperthermia, InducedTherapeutics

Study Officials

  • Mohamed Abd elfattah elsenitt, Lecturer

    Ain Shams University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mohamed Abd elfatah el senity, Lecturer

CONTACT

Ahmad Yousef riad, M.B.B.C.H

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Allocation and concealment will be done by sequentially sealed opaque envelopes. 60 envelopes will be numbered serially from 1 to 60, 30 envelopes will contain the letter c and the other 30 will contain the letter S. In each envelope, the corresponding letter which donates the allocated group will be put according to the randomization table and them all envelopes will be closed and put in one box. When the first patient arrives, the first envelope will be opened and the patient will be allocated according to the letter inside.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The study population comprises females in childbearing period underwent laparoscopic ovarian cystectomy at Ain Shams University Maternity Hospital, Obstetric and Gynecology Department, Faculty of medicine.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of obstetrics and gynecology

Study Record Dates

First Submitted

June 15, 2019

First Posted

June 18, 2019

Study Start

March 15, 2019

Primary Completion

September 20, 2019

Study Completion

September 20, 2019

Last Updated

June 18, 2019

Record last verified: 2019-06

Locations